// App-Quantinova.ai

4939 : Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure

Researchers

Presenter

  • J Ishii

Principal Investigators

  • G Nishimura

  • H Takahashi

  • H Kawai

  • T Muramatsu

  • M Harada

  • S Motoyama

  • H Naruse

  • E Watanabe

  • M Hayashi

Medical Centers

  • Dept of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan

  • Departments of Surgery, Fujita Health University School of Medicine, Toyoake, Japan

  • Division of Statistics, Fujita Health University School of Medicine, Toyoake, Japan

  • Dept of Cardiology, Banbuntane Hotokukai Hospital, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • B-type natriuretic peptide

  • Cluster of Differentiation 14

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved